摘要中国康辰医药股份有限公司于2009年3月25日在北京宣布其自主研发的国家一类止血新药——注射用尖吻蝮蛇血凝酶（Haemocoagulase Agkisvodon For Iniection，商品名：苏灵）在国内上市。该药的研发始于1998年，2001年完成全部临床前研究，2002年8月获得SFDA颁发的“药物临床研究批件”并进入临床试验研究阶段。
出处《中国执业药师》CAS
2009年第5期54-54,共1页
China Licensed Pharmacist
3Van Dong L, Quyen le K, Eng KH, et al. Immunogenieity of venom from four eomman snakes in the South of Vietnam and development of ELISA kit for venom detection [J]. Immunol Methods, 2003, 2820/2):13-31.
4Tang SS, Zhang JH, Tang BS,et al. Biochemical and hemostatic mecha- nism of anovel thrombin-like enzyme [J]. Thrombosis Research, 2009,124(5):631-639.
5Nakata S,Miyazaki S,Ohki M,et al. Red uced nasal resistance after sim- ple tonsil lectomy in patients with obstructive sleep apnea[J].Am J Rhi- nol, 2007,21(2):192-195.
6Kim ST,Choi JHJeon HG,et al.Poly somnographic effects of nasal srugery for snoring and obstructive sleep apnea[J].Acta Otolaryngol.2004; 124(3):297-300.
7Nielsen VG,Levy JH. Fibrinogen and bleeding:old molecule-new ideas. Anesthesia and Analgesia,2007,105(4):902-903.
